Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 120054
Published online Dec 9, 2026. doi: 10.5409/wjcp.120054
Published online Dec 9, 2026. doi: 10.5409/wjcp.120054
Table 1 Demographic and clinical characteristics of patients, median (interquartile range)/n (%)
| Characteristics | Total, n = 175 | Survivors, n = 151 | Non-survivors, n = 24 | P value |
| Age in months | 48 (12-126) | 42 (12-132) | 54 (4.7-102) | 0.845 |
| Age subgroups | ||||
| 1-12 months | 56 | 49 (87.5) | 7 (12.5) | 0.686 |
| 13-60 months | 46 | 40 (87) | 6 (13) | |
| 61-120 months | 29 | 23 (79.3) | 6 (20.7) | |
| > 120 months | 44 | 39 (88.6) | 5 (11.4) | |
| Gender | ||||
| Male | 96 | 85 (88.5) | 11 (11.5) | 0.339 |
| Female | 79 | 66 (83.5) | 13 (16.5) | |
| Primary diagnosis | ||||
| Respiratory disease | 41 | 41 (100.0) | 0 | 0.372 |
| Renal disease | 2 | 2 (100.0) | 0 | |
| Sepsis | 30 | 15 (50.0) | 15 (50.0) | |
| Neurological disease | 43 | 41 (95.2) | 2 (4.7) | |
| Cardiac disease | 10 | 10 (100.0) | 0 | |
| Postoperative | 1 | 1 (100.0) | 0 | |
| Oncology | 8 | 6 (75.0) | 2 (25.0) | |
| Trauma | 2 | 1 (50.0) | 1 (50.0) | |
| Endocrine | 4 | 0 | 4 (100.0) | |
| Hepatic disease | 6 | 4 (66.7) | 2 (33.3) | |
| Poisoning | 9 | 9 (100.0) | 0 | |
| Metabolic disease | 1 | 0 | 1 (100.0) | |
| Gastrointestinal disease | 18 | 17 (94.4) | 1 (5.6) | |
| Mechanical ventilation in first 24 hours | 25 | 9 (36) | 16 (64) | < 0.001 |
| Inotropes in first 24 hours | 26 | 14 (53.8) | 12 (46.2) | < 0.001 |
| Duration of PICU stay (days) | 3 (1-5) | 3 (1-4) | 4 (2-7) | 0.031 |
| Duration of total hospital stay (days) | 5 (4-9) | 6 (4-9) | 4 (2-7) | 0.011 |
| Referred out | 13 | 7 (53.8) | 6 (46.2) | 0.231 |
Table 2 Comparison of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores between survivors and non-survivors, mean ± SD/median (interquartile range)
| Survivors, n = 151 | Non survivors, n = 24 | Total, n = 175 | P value | AUROC (95%CI) | Observed death (O) | Expected death (E) | SMR (O/E) 95%CI | Calibration HL-GOF | |
| PRISM-III | 4.35 ± 3.92 | 13.04 ± 7.68 | 5.54 ± 5.55 | < 0.001 | 0.884 (0.827-0.927) | 24 | 23 | 1.04 (0.63-0.46) | χ2 = 2.69, P = 0.952 |
| 3 (2-6) | 10.5 (6-18) | 4 (2-7) | |||||||
| PIM-3 | 2.52 ± 1.75 | 18.79 ± 28.31 | 4.75 ± 1.84 | < 0.001 | 0.951 (0.907-0.978) | 24 | 24 | 1.0 (0.64-1.47) | χ2 = 5.592, P = 0.692 |
| 2.1 (1.6-2.8) | 8.6 (4-13.5) | 2.3 (1.7-3.5) | |||||||
| PELOD-2 | 1.74 ± 2.08 | 7.08 ± 4.20 | 2.47 ± 3.07 | < 0.001 | 0.939 (0.893-0.970) | 24 | 23 | 1.04 (0.63-1.46) | χ2 = 7.36, P = 0.518 |
| 2 (0-2) | 7 (4-9) | 2 (0.6-3) |
Table 3 Age-stratified predictive performance of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores
| PRISM-III | PIM-3 | PELOD-2 | |
| Age group 1-12 months | |||
| mean ± SD | 4.52 ± 5.48 | 4.85 ± 11.70 | 2.64 ± 2.75 |
| median (interquartile range) | 3 (1.5-6) | 2.6 (1.9-3.1) | 2 (2-3) |
| AUROC (95%CI) | 0.856 (0.656-1.000) | 0.845 (0.550-1.000) | 0.883 (0.722-0.990) |
| Observed death (O) | 7 | 7 | 7 |
| Expected death (E) | 7 | 6 | 7 |
| SMR (O/E) 95%CI | 1 | 1.2 | 1 |
| HL χ2 | 1.55 | 7.07 | 1.72 |
| P value | 0.907 | 0.53 | 0.423 |
| Age group 13-60 months | |||
| mean ± SD | 5.61 ± 5.61 | 5.19 ± 13.74 | 2.26 ± 3.30 |
| median (interquartile range) | 4 (2.2-6.8) | 2.3 (1.8-3.7) | 1.5 (0-2) |
| AUROC (95%CI) | 0.872 (0.701-1.000) | 0.976 (0.925-1.000) | 0.982 (0.938-1.000) |
| Observed death (O) | 6 | 6 | 6 |
| Expected death (E) | 5 | 6 | 6 |
| SMR (O/E) 95%CI | 1.2 | 1 | 1 |
| HL χ2 | 5.84 | 2.58 | 6.14 |
| P value | 0.441 | 0.958 | 0.105 |
| Age group 61-120 months | |||
| mean ± SD | 6.97 ± 6.20 | 2.87 ± 2.57 | 3.14 ± 3.69 |
| median (interquartile range) | 5 (2-10) | 2.1 (1.4-3.7) | 2 (0-6) |
| AUROC (95%CI) | 0.812 (0.635-0.953) | 0.884 (0.718-1.000) | 0.783 (0.530-0.971) |
| Observed death (O) | 6 | 6 | 6 |
| Expected death (E) | 6 | 5 | 6 |
| SMR (O/E) 95%CI | 1 | 1.2 | 1 |
| HL χ2 | 7.65 | 12.06 | 4.17 |
| P value | 0.468 | 0.149 | 0.383 |
| Age group > 120 months | |||
| mean ± SD | 5.93 ± 5.06 | 5.41 ± 13.68 | 2.05 ± 2.77 |
| median (interquartile range) | 5 (2-7) | 2.05 (1.6-3.55) | 1 (0-3) |
| AUROC (95%CI) | 0.849 (0.640-1.000) | 0.764 (0.333-1.000) | 0.879 (0.660-1.000) |
| Observed death (O) | 5 | 5 | 5 |
| Expected death (E) | 5 | 4 | 5 |
| SMR (O/E) 95%CI | 1 | 1.3 | 1 |
| HL χ2 | 10.06 | 8.99 | 4.02 |
| P value | 0.185 | 0.343 | 0.546 |
Table 4 Diagnostic accuracy of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores
| Mortality | Total, 175 | Sensitivity, % | Specificity, % | PPV, % | NPV, % | Diagnostic accuracy | |||
| Yes, 24 | No, 151 | ||||||||
| PRISM-III | > 6 | 17 | 33 | 50 | 70.8 | 78.1 | 34 | 95.4 | 77.1 |
| ≤ 6 | 7 | 118 | 125 | ||||||
| PIM-3 | > 3.6 | 19 | 23 | 42 | 79.2 | 84.8 | 45.2 | 96.2 | 84 |
| ≤ 3.6 | 5 | 128 | 133 | ||||||
| PELOD-2 | > 3.8 | 21 | 29 | 50 | 87.5 | 80.8 | 42 | 97.6 | 81.7 |
| ≤ 3.8 | 3 | 122 | 125 | ||||||
- Citation: Sood M, Modi S, Sood I. Performance of PIM, PRISM, and PELOD scores in a resource-limited North Indian paediatric intensive care unit. World J Clin Pediatr 2026; 15(4): 120054
- URL: https://www.wjgnet.com/2219-2808/full/v15/i4/120054.htm
- DOI: https://dx.doi.org/10.5409/wjcp.120054